Zhou, Lili External Entity

Publications

Sort by

Selected publications

  • CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.  Cancer immunology research2014 Academic Article GET IT
    Times cited: 13

Other